The Health Roundtable 1-1b_HRT1215-Session_HEGI_JOHNSON_WESTMEAD_NSW Volumetric Modulated Arc Therapy for Stereotactic Body Radiotherapy in Early Lung.

Slides:



Advertisements
Similar presentations
10th Annual Lung Cancer Conference Radiation Oncology
Advertisements

The Health Roundtable Planned Patient Arrival Update Presenter: Rochelle Condon Austin Hospital Innovation Poster Session HRT1215 – Innovation Awards Sydney.
Radiotherapy for Brain Tumours What do I need to know? Dr Matthew Foote Radiation Oncologist Princess Alexandra Hospital Queensland.
Stereotactic Body Radiation Therapy (SBRT): The optimal indication for operable tumors in inoperable patients D.Katsochi 1, S.Kosmidis 1, A.Fotopoulou.
Volumetric Modulated Arc Therapy (VMAT)
Radiotherapy Planning for Esophageal Cancers Parag Sanghvi, MD, MSPH 9/12/07 Esophageal Cancer Tumor Board Part 1.
Stereotactic body radiation therapy for T1N0M0 non-small cell lung cancer. First report for inoperable population of a phase II trial by Japan Clinical.
Shannon M MacDonald 1, Salahuddin Ahmad 2, Stefanos Kachris 3, Betty J Vogds 2, Melissa DeRouen 3, Alicia E Gitttleman 3, Keith DeWyngaert 3, Maria T Vlachaki.
The Health Roundtable Charting a course for change for people with chronic illness: The St George experience Presenters: Linda Soars, Daniel Shaw, Karen.
Vertebral Fractures After Stereotactic Ablative Radiotherapy of Lung Tumors Todd A. Aguilera MD PhD 1, Nicholas Trakul MD PhD 2, David B. Shultz MD PhD.
Measurement of Dose to Critical Structures Surrounding the Prostate from Intensity-Modulated Radiation Therapy (IMRT) and Three Dimensional Conformal Radiation.
Comparison of Rectal Dose Volume Histograms for Definitive Prostate Radiotherapy Among Stereotactic Radiotherapy, IMRT, and 3D-CRT Techniques Author(s):
Evaluating a Nomogram for the Development of Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer Treated with 3D and Intensity Modulated.
INTRODUCTION  The majority of clinical trials addressing outcomes in limited- stage small cell lung cancer (LS-SCLC) following definitive chemoradiotherapy.
The Health Roundtable 4-4c_HRT1215-Session_CLARK_PCHosp_QLD TPCH: Using Data to Improve Performance – The Clinical Dashboard Presenter: Kevin Clark The.
The Health Roundtable CSA level monitoring from Hickman line Vs peripherally Presenter: Dalia Joseph Health Service: Melbourne Health Bone Marrow Transplant.
CTOS Soft Tissue Sarcoma of the Extremity Comparison of Conformal Post-operative Radiotherapy (CRT) and Intensity Modulated Radiotherapy (IMRT)
The Health Roundtable 3-3a_HRT1215-Session_NEILSON_AUSTIN_VIC Care of the Patient with a Fractured Neck of Femur Presenter: Fiona Nielsen Hospital Austin.
Clinico-Dosimetric Correlation for Acute and Chronic Gastrointestinal Toxicity in Patients of Locally Advanced Carcinoma Cervix Treated With Conventional.
The Health Roundtable “Burdening the Shoulder? Don’t Shoulder the Burden!” Presenter: Judy Chen Hospital Code Name: The Prince of Wales Hospital Innovation.
The Health Roundtable Hospital 2 Home – Heart Failure Pathway, Reducing Readmissions Presenter: Dr Stephen Jennison Whangarei NZ Innovation Poster Session.
Dosimetric discrepancies due to positional errors in MLC movement during stereotactic lung VMAT A. Abbas, T. Karan, S. Kim, D. J. Moseley, M. M. Taremi,
The Health Roundtable Improving data collection rates, while improving quality Presenter: Sandra Avery Liverpool Innovation Poster Session HRT1215 – Innovation.
The Health Roundtable Hip and Knee Replacement Improvement Project – Patient Goal Driven Care Presenter: Peter Faulkner Bendigo Innovation Poster Session.
3. Results (continued) Of single fraction regimens, 87% prescribed ≥16 Gy. Single fraction treatments were constrained by maximum spinal cord doses of.
The Health Roundtable Saving heart muscle by reducing delays to getting patients to the overnight regional catheter lab Presenter: Debby Hailstone Middlemore.
The Health Roundtable Improving Patient Flow in Orthopaedic Inpatients Presenter: Kathy Flanigan - Nursing Director Hospital QE11 – Vic Innovation Poster.
The Health Roundtable Improving the patient journey through ED Presenter: Kate Jurd Health Service: Toowoomba Hospital Innovation Poster Session HRT1215.
The Health Roundtable 3-3b_HRT1215-Session_C_THOMPSON_Womens_VIC STEPS Towards Excellence in Perioperative Nursing Presenter: Charmayne Thompson The Womens.
The Health Roundtable Project RED: Roll out of electronic ordering from ED to Radiology Presenter: Jayne Morris St Vincents Sydney Innovation Poster Session.
The Health Roundtable 4-4c_HRT1215-Session_TRENTINO_CG_WA Reporting Hospital Acquired Complications using CHADx: Our Experience Presenter: Kevin Trentino.
The Health Roundtable Decreasing Error Rates in Theatre Sterile Supply Presenter: Peter Mason HospitalQE2 Innovation Poster Session HRT1215 – Innovation.
Tumor Location Correlates with Radiation Pneumonitis after Stereotactic Body Radiation Therapy (SBRT) for Primary and Oligometastatic Lesions of the Lung.
The Health Roundtable Electronic Medication Management Presenter: Dr Melissa Baysari UNSW Innovation Poster Session HRT1215 – Innovation Awards Sydney.
Optimization of Volumetric Modulated Arc Therapy (VMAT) Planning Strategy Using Ring-shaped ROI for Localized Prostate cancer Kentaro Ishii, Masako Hosono,
The Health Roundtable 3-3c_HRT1215-Session_SMEATON_ISHLHD_NSW High Five DRG Project Presenter: Alexander Smeaton Hospital Wollongong Innovation Poster.
The Health Roundtable Using ART to get Bang for Buck – Systematic prioritisation to deliver medication safety interventions Presenter: Sanjoy Nand Hospital.
Saad El Din I, M.D *, Abd El AAl H, M.D *, Makaar W, M.D *, El Beih D, M.Sc †, Hashem W, M.Sc * *Department of Clinical Oncology and Radiotherapy, Kasr.
Reducing excess imaging dose to cancer patients receiving radiotherapy Adam Schwertner, Justin Guan, Xiaofei Ying, Darrin Pelland, Ann Morris, Ryan Flynn.
第三讲: Basic treatment planning - Dengsong Zhu, MS, DABR Medical Physicist Radiation Safety Officer.
SARC018: A SARC PILOT MULTICENTER STUDY OF PREOPERATIVE RADIATION AND SURGERY IN PATIENTS WITH HIGH- RISK DESMOID TUMORS Robert S. Benjamin, M.D.
Stereotactic Body Radiation Therapy for Early Stage Prostate Cancer: Outcomes from a Single Institution Study Stereotactic Body Radiation Therapy for Early.
Carmel McDerby Clatterbridge Centre for Oncology, Merseyside,UK
Measurements of the photon and neutron dose delivered to organs outside the radiation beams for 3DCRT and IMRT radiotherapy A. Kowalik 1, W. Jackowiak.
Lung SBRT Implementation at the Regional Cancer Centre
Radiation therapy for Early Stage Prostate Cancer
Kasey Etreni BSc., MRT(T), RTT, CTIC
Extending intracranial treatment options with Leksell Gamma Knife® Icon™ Key Statements from Customer Perspective by University Medical Centre Mannheim.
Feasibility of hippocampal sparing radiation therapy for glioblastoma using helical Tomotherapy Dr Kamalram THIPPU JAYAPRAKASH1,2,3, Dr Raj JENA1,4 and.
Introduction Materials & Methods Results Conclusion
Evaluation Of RTOG Guidelines For Monte Carlo Based Lung SBRT Planning
*Can the volume predict the acute reactions ?
Quality of treatment plans and accuracy of in vivo portal dosimetry in hybrid intensity- modulated radiation therapy and volumetric modulated arc therapy.
Reducing Treatment Time and MUs by using Dynamic Conformal Arc Therapy for SBRT Breath-Hold Patients Timothy Miller, Sebastian Nunez Albermann, Besil Raju,
VMAT-technique (volumetric modulated arc therapy), IMRT-technique (intensity modulated radiotherapy) and 3D-conformal radiation for Lymphomas in Radiation.
Insert tables Insert figure
Insert tables Insert graphs Insert figure
Radiation Oncology New Techniques + Technologies
Volumetric Modulated Arc Therapy (VMAT) versus Intensity Modulated Radiation Therapy (IMRT) for Anal Carcinoma Heather Ortega, BSRT(T), CMD, Kerry Hibbitts,
Dosimetry of Alternative Techniques for Accelerated Partial Breast Irradiation Hanh Pham, B.S, CMD, Thanh Nguyen, BS, Christina Henson, MD, Salahuddin.
Insert tables Insert graphs Insert figure
Radiation Oncology Department, Bank of Cyprus Oncology Center.
A Multi-Institutional Dosimetric Evaluation of Proton Versus Photon Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma F. Khan, B. Nguyen,
Figure 4 Dosimetric comparison of LDR‑BT versus HDR‑BT
Figure 2 Nonmalignant tissue can be spared from radiation
Figure 4 Treatment plans using stereotactic body radiotherapy (SBRT)
Intensity-Modulated Radiotherapy for Lung Cancer: Current Status and Future Developments  Clara Chan, MD, Stephanie Lang, MSc, Carl Rowbottom, PhD, Matthias.
Hemithoracic Radiotherapy After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma: A Dosimetric Comparison of Two Well-Described Techniques 
GHG meeting at ESTRO36 May, 2017
Average Dose-Volume Ratio
Presentation transcript:

The Health Roundtable 1-1b_HRT1215-Session_HEGI_JOHNSON_WESTMEAD_NSW Volumetric Modulated Arc Therapy for Stereotactic Body Radiotherapy in Early Lung Cancer. Dr Fiona Hegi-Johnson Westmead Hospital Innovation Poster Session HRT1215 – Innovation Awards Sydney 11 th and 12 th Oct

The Health Roundtable KEY PROBLEM  Stereotactic body radiotherapy(SBRT) for early lung cancer results in excellent local control and potentially improved survival 1. 3D-conformal radiotherapy(3D-CRT) and intensity modulated radiation therapy( IMRT) delivery require long treatment times, increasing the risk of patient motion.  Volumetric arc therapy(VMAT) may result in improved dosimetric outcomes, and potentially reduced treatment time. 1. Chi et al. Radiotherapy and Oncology 94(2010):

The Health Roundtable AIM OF THIS INNOVATION  Assess dosimetric outcomes of implementing VMAT for SBRT lung  Quantify time required for treatment of SBRT lung patients 3

The Health Roundtable BASELINE DATA  Stereotactic Body Radiotherapy (SBRT) lung:  Very small volumes treated to high doses ( typically Gy in 3- 5 fractions)  Demands high conformality of radiotherapy dose, with rapid fall-off from high dose region  Previous techniques in use:  3D-Conformal radiotherapy  Intensity modulated radiotherapy  Use beams, often requiring non-coplanar beams  Up to 1 hour in treatment time  Uncomfortable for patients, and increases the risk of tumour motion during treatment. 4

The Health Roundtable KEY CHANGES IMPLEMENTED  Pinnacle VMAT plans compared to coplanar (CP) and non- coplanar (NCP) 3D-CRT and IMRT plans for delivery on Elekta Linacs and assessed for:  Target coverage with the prescribed dose and 98% coverage of the PTV  Low dose wash at 2 cm from target  V20 (volume of normal lung receiving 20 Gy).  3 patients included  All patients received 48 Gy in 4 fractions given twice weekly. 5

The Health Roundtable KEY CHANGES IMPLEMENTED ParameterVMAT3D-CRT CP3D-CRT NCP IMRT CPIMRT NCP PTV coverage 98.2%94.5%95.1%95.5%97.1% V206.0%5.6%4.5%5.5%5.1% D2cm26.9Gy33.4Gy28.9Gy29.4Gy25.4Gy 6

The Health Roundtable KEY CHANGES IMPLEMENTED Clinical treatment time: 35 minutes 7

The Health Roundtable OUTCOMES SO FAR  VMAT demonstrated to improve target coverage compared other techniques (>98% vs %)  V20 higher with VMAT 6% vs %.  Low dose wash superior to 3D-CRT (Co-planar and non- coplanar) and co-planar IMRT.  Treatment time reduced to 35 minutes. 8

The Health Roundtable LESSONS LEARNT  Choice of radiotherapy technique:  Consider technical factors  Ease of implementation  Need for further training  Future considerations:  VMAT funding significantly lower than other techniques, as reimbursement is based on the number of beams, and fractions delivered.  Currently under negotiation, but may make this expensive for departments to implement. 9